BioSpace News Archive

Strategic collaboration to further develop olamkicept highlights Ferring’s continued commitment to innovation in gastroenterology and inflammatory bowel disease.

STADA and Alvotech broaden European patients’ options by launching Hukyndra ® high-concentration, citrate-free adalimumab.

bluebird bio stock trading halted today June 9th and tomorrow June 10th.

Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA) and Aurigene Discovery Technologies Limited (“Aurigene”) today announced an exclusive global license agreement to research, develop and commercialize novel small molecule inhibitors of an undisclosed oncology target.

31 new and encore presentations, including three late-breakers and three oral presentations, spotlight robust Nurtec ODT, zavegepant and migraine HEOR data.

Immunocore Holdings plc today announces the appointment of Siddharth (Sid) Kaul as a non-Executive member of its Board of Directors, effective June 8, 2022.

BIONIK Laboratories Corp. (OTCPink: BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today reported financial results for the fourth quarter and fiscal year 2022, ended March 31, 2022.

Clinscience extends Calyx’s reliable, expedited imaging services to its global pharmaceutical customers.

Teva to Present Latest Data on AJOVY ® (fremanezumab-vfrm) Injection at the 2022 American Headache Society Annual Meeting.

Eyenovia, Inc., an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print investigational products, announced that its Annual Meeting of Stockholders will be held virtually via live webcast on Thursday, June 16, 2022 at 10:00 am EDT.